Repare Therapeutics Inc logo

Repare Therapeutics Inc

NAS:RPTX (Canada)   Ordinary Shares
$ 6.27 +0.11 (+1.79%) 08:08 PM EST
At Loss
P/B:
1.11
Market Cap:
$ 257.88M
Enterprise V:
$ 18.43M
Volume:
96.03K
Avg Vol (2M):
198.07K
Volume:
96.03K
At Loss
Avg Vol (2M):
198.07K

Business Description

Repare Therapeutics Inc logo
Repare Therapeutics Inc
NAICS : 541714 SIC : 3741
ISIN : US7602731025

Share Class Description:

RPTX: Ordinary Shares
Description
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.
Name Current Vs Industry Vs History
Cash-To-Debt 63.73
Equity-to-Asset 0.82
Debt-to-Equity 0.02
Debt-to-EBITDA -0.04
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.51
Distress
Grey
Safe
Beneish M-Score -1.2
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 27.4
3-Year EPS without NRI Growth Rate 16.6
3-Year FCF Growth Rate 79.8
Name Current Vs Industry Vs History
5-Day RSI 24.27
9-Day RSI 34.64
14-Day RSI 40.42
6-1 Month Momentum % -36.71
12-1 Month Momentum % -40.53

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.62
Quick Ratio 5.62
Cash Ratio 5.11

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -10.1
Shareholder Yield % 0.77

Financials (Next Earnings Date:2024-02-28 Est.)

RPTX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:RPTX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Repare Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 56.284
EPS (TTM) ($) -2.31
Beta 0.72
Volatility % 110.25
14-Day RSI 40.42
14-Day ATR ($) 0.63158
20-Day SMA ($) 7.04805
12-1 Month Momentum % -40.53
52-Week Range ($) 3.08 - 13.85
Shares Outstanding (Mil) 42.13

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Repare Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Repare Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Repare Therapeutics Inc Frequently Asked Questions

What is Repare Therapeutics Inc(RPTX)'s stock price today?
The current price of RPTX is $6.27. The 52 week high of RPTX is $13.85 and 52 week low is $3.08.
When is next earnings date of Repare Therapeutics Inc(RPTX)?
The next earnings date of Repare Therapeutics Inc(RPTX) is 2024-02-28 Est..
Does Repare Therapeutics Inc(RPTX) pay dividends? If so, how much?
Repare Therapeutics Inc(RPTX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1